Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1997 3
1998 1
1999 6
2000 2
2002 1
2003 3
2004 2
2005 3
2007 1
2008 1
2009 2
2010 2
2011 1
2012 5
2013 6
2014 2
2018 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
A case of platelet transfusion refractoriness in a CD36-negative patient with acute myeloid leukemia: Diagnostic and therapeutic management.
Pedini P, Hicheri Y, Bertand G, Dettori I, Basire A, Lazaygues C, Chabrières C, Perrin C, Pascal J, Chiaroni J, Renac V, Ladaique P, Vey N, Picard C. Pedini P, et al. Among authors: ladaique p. Transfusion. 2022 Oct;62(10):2148-2150. doi: 10.1111/trf.17093. Transfusion. 2022. PMID: 36214575 Free PMC article. No abstract available.
Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathogen inactivation technology (INTERCEPTTM Blood System) in acute myeloid leukemia patients undergoing chemotherapy with curative intent: a single center experience.
Ladaique P, Etienne JM, Pedini P, Chiaroni J, Vey N, Picard C, Chabrieres C. Ladaique P, et al. Blood Transfus. 2023 Sep;21(5):400-408. doi: 10.2450/2023.0143-22. Epub 2023 Feb 10. Blood Transfus. 2023. PMID: 36795348 Free PMC article.
Donor CD3(+) lymphocyte infusion after reduced intensity conditioning allogeneic stem cell transplantation: single-center experience.
El-Cheikh J, Crocchiolo R, Furst S, Ladaique P, Castagna L, Faucher C, Calmels B, Oudin C, Lemarie C, Granata A, Devillier R, Vey N, Bouabdallah R, Chabannon C, Blaise D. El-Cheikh J, et al. Among authors: ladaique p. Exp Hematol. 2013 Jan;41(1):17-27. doi: 10.1016/j.exphem.2012.09.008. Epub 2012 Sep 25. Exp Hematol. 2013. PMID: 23022128
Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial.
Garban F, Guyard A, Labussière H, Bulabois CE, Marchand T, Mounier C, Caillot D, Bay JO, Coiteux V, Schmidt-Tanguy A, Le Niger C, Robin C, Ladaique P, Lapusan S, Deconinck E, Rolland C, Foote AM, François A, Jacquot C, Tardivel R, Tiberghien P, Bosson JL; Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process (EFFIPAP) Study Group. Garban F, et al. Among authors: ladaique p. JAMA Oncol. 2018 Apr 1;4(4):468-475. doi: 10.1001/jamaoncol.2017.5123. JAMA Oncol. 2018. PMID: 29392283 Free PMC article. Clinical Trial.
Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma.
El-Cheikh J, Crocchiolo R, Furst S, Ladaique P, Castagna L, Faucher C, Granata A, Oudin C, Lemarie C, Calmels B, Stoppa AM, Schiano De Colella JM, Duran S, Chabannon C, Blaise D. El-Cheikh J, et al. Among authors: ladaique p. Exp Hematol. 2012 Jul;40(7):521-7. doi: 10.1016/j.exphem.2012.02.009. Epub 2012 Mar 23. Exp Hematol. 2012. PMID: 22446605 Free article. Clinical Trial.
Impact of antithymocyte globulin on the need for platelet transfusions during reduced-intensity conditioning administration before allogeneic stem cell transplantation.
Granata A, Castagna L, Crocchiolo R, Fürst S, El Cheikh J, Oudin C, Ladaique P, Lemarie C, Calmels B, Faucher C, Chabannon C, Blaise D. Granata A, et al. Among authors: ladaique p. Exp Hematol. 2013 Jun;41(6):503-5. doi: 10.1016/j.exphem.2013.02.010. Epub 2013 Feb 24. Exp Hematol. 2013. PMID: 23462144 Free article. No abstract available.
Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma.
El Cheikh J, Kfoury E, Calmels B, Lemarie C, Stoppa AM, Bouabdallah R, Coso D, Schiano De Collela JM, Ladaique P, Gastaut JA, Mohty M, Chabannon C, Blaise D. El Cheikh J, et al. Among authors: ladaique p. Hematol Oncol Stem Cell Ther. 2011;4(1):30-6. doi: 10.5144/1658-3876.2011.30. Hematol Oncol Stem Cell Ther. 2011. PMID: 21460604 Free article.
42 results